GEZ-15648-88072
3 vaccinations
1 coded response
8 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 460 / IN
- Registered
- 2022-10-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-20
Dose 1 — Pfizer-BioNTech
-
2021-05-11
Dose 2 — Pfizer-BioNTech
-
2022-10-09
Dose 3 — Pfizer-BioNTech
-
2022-10-16
Registered in v-safe
- 2022-10-16
- 2022-10-24
- 2022-10-30
- 2022-11-06
- 2022-11-13
- 2022-11-20
- 2023-01-08
-
2023-04-09
Survey response — 6 months, dose 3MedDRA: Fatigue, Headache, Migraine, Vomiting — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-04-09
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2023-04-10
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-20 | Pfizer-BioNTech | No |
| 2 | 2021-05-11 | Pfizer-BioNTech | No |
| 3 | 2022-10-09 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release